Larry Todd Edwards serves as Executive at Arcutis Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Larry Todd Edwards has executed 8 insider transactions totaling $944.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 2, 2026 involved selling 2,052 shares valued at $52.3K.
Larry Todd Edwards currently holds 148,865 shares of Arcutis Biotherapeutics, Inc. (ARQT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Larry Todd Edwards has been a net seller of ARQT stock. They have purchased $0 and sold $944.1K worth of shares.
Larry Todd Edwards's most recent insider trade was on Feb 2, 2026, when they sold 2,052 shares at $25.50 per share.
Get notified when new Form 4 filings are submitted
| $25.16 |
| Discretionary |
| Oct 2, 2025 | ARQT | $6.2K | Sale | 297 | $20.78 | Discretionary |
| Oct 2, 2025 | ARQT | $84.1K | Sale | 4,207 | $19.99 | Discretionary |
| May 17, 2024 | ARQT | $68.6K | Sale | 7,640 | $8.98 | Discretionary |
| May 16, 2024 | ARQT | $0 | Award | 60,000 | $N/A | Discretionary |
| Jan 12, 2024 | ARQT | $0 | Award | 28,000 | $N/A | Discretionary |
| Sep 27, 2023 | ARQT | $0 | Award | 60,000 | $N/A | Discretionary |